Vigonvita Life Sciences Co., Ltd. plans to offer 17,597,800 H Shares globally, comprising 1,759,800 Hong Kong Offer Shares and 15,838,000 International Offer Shares. In addition, an Over-allotment Option of up to 2,639,600 H Shares (representing 15% of the initial total) may be exercised to cover over-allocations in the International Offering if needed.

The maximum Offer Price is set at HK$34.00 per H Share, with a price range expected not to fall below HK$32.00. The Hong Kong Public Offering is scheduled from 9:00 a.m. on October 28, 2025, to 12:00 noon on November 3, 2025 (Hong Kong time). Subject to final conditions, dealings in the H Shares on the Stock Exchange are anticipated to begin on November 6, 2025, at 9:00 a.m., with board lots of 200 H Shares each.

Key dates include a Price Determination Date on or before November 4, 2025, and a final allocation announcement on or before November 5, 2025. The stock code of the H Shares is 2630, and the nominal value is RMB1.00 per H Share.